April 08, 2015

A scientific study has shown that the newly created molecule UM171 can increase the number of stem cells in stored cord blood. When you choose to store your child’s cord blood during one of your stages of pregnancy, you can be confident that your child will have a greater chance of having their health restored, should they develop one of the more than 80 diseases that umbilical cord blood is currently known to treat. The finding involving molecule UM171 means that cord blood can be more widely used in various treatments.

What is stem cell research, in relation to cord blood? Stem cell transplants from the blood found in newborn’s umbilical cords can be used to treat blood diseases, such as leukemia and lymphoma, and can also be used in anemia treatment. Cord blood can be useful when a patient’s blood-producing marrow has been destroyed by chemotherapy or radiation. It provides fresh stem cells, which can form into healthy and mature blood cells. This process can be used when patients are unable to find an identical match for a bone marrow transplant.

Guy Sauvageau, a stem cell researcher and hematologist from Montreal, was the co-author of the study that revealed the findings involving molecule UM171. Currently, not all stored cord blood samples can be used for a transplant, if their stem cell counts are too low. This does not happen in all cases, but can happen from time to time. But now, this new molecule has the potential to make substantially more umbilical cord blood units suitable for transplants. Now that they have discovered this molecule, Sauvageau and his team have modified it, so that it can become more potent and useful in the cord blood banking progress.

Just as the human body changes rapidly through the various pregnancy stages, so is cord blood and stem cell research continually expanding and evolving. It’s certainly not a bad idea to choose to store your child’s cord blood with CariCord during the earlier stages of pregnancy, before life becomes too hectic.

FaceBook  Twitter